This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vividion Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: I-Chung Lo: Innovator in Nrf2 Inhibition
Introduction
I-Chung Lo is an inventor based in San Diego, CA (US). He is known for his work in the field of biochemistry, particularly focusing on compounds and methods for inhibiting Nrf2 by activating KEAP1. Although he currently holds no granted patents, his contributions to innovation are noteworthy.
Latest Patent Applications
I-Chung Lo has submitted a patent application titled "INHIBITORS AND USES THEREOF - Compounds and methods for inhibiting Nrf2 by activating KEAP1." This application reflects his ongoing research and commitment to advancing scientific knowledge in his area of expertise.
Conclusion
I-Chung Lo is an emerging inventor whose work in Nrf2 inhibition showcases his potential to contribute significantly to the field of biochemistry. His latest patent application indicates a promising direction for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile